86 completed, 32 recruiting, 27 unknown, 22 not yet recruiting. 72 Not applicable, 12 Phase 1, 12 Phase 3, 11 Phase 2, 5 Phase 4.
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers Ervebo, Inmazeb - Ebola Virus Disease | Phase 2 | Not yet recruiting | ANRS, Emerging Infectious Diseases | 132 | 2027-01-01 | 2026-01-22 |
| GENES AND AUTISM - Induced Pluripotent Stem Cells Blood Sample : isolation of peripheral blood mononuclear cells (PBMCs) - Autism Disorder, ASD | Not applicable | Not yet recruiting | Institut National de la Santé Et de la Recherche Médicale, France | 450 | 2026-12-01 | 2026-09-25 |
| Testing of a New Rapid Antigen Test for Plague in Ituri, Democratic Republic of the Congo. Plague, Bubonic; Plague, Skin | Not yet recruiting | Institute of Tropical Medicine, Belgium | 300 | 2026-12-01 | 2026-09-29 | |
| Assessment of the Acceptability of, and Factors Associated With, Recommended Vaccinations During Pregnancy in Maternity Units in the Ile-de-France Region Vaccination Coverage Among Pregnant Women | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 1605 | 2026-11-01 | 2026-10-20 | |
| Biomarkers for Post-treatment Control in HIV: International Study of the EU2Cure Research Consortium (Phase I) No Intervention: Observational Cohort - HIV | Not yet recruiting | Erasmus Medical Center | 200 | 2026-10-01 | 2026-07-09 | |
| A Trial to Evaluate the Safety, Immunogenicity and the Optimal Dose of MOPEVAC-Las Vaccine Candidate Against Lassa Fever Low dose MOPEVAC-Las vaccine, Intermediate dose MOPEVAC-Las vaccine, High dose MOPEVAC-Las vaccine - Lassa Fever | Phase 1 | Recruiting | Institut Pasteur | 72 | 2026-09-28 | 2026-10-13 |
| Optimization of Perceived Sound Quality for Music Listening in Hearing Aid Users With Hearing Loss. Musical listening quality preference test - Hearing Impaired (Partially) | Not yet recruiting | Institut Pasteur | 66 | 2026-09-01 | 2026-07-01 | |
| Cognitive Processing of Natural Sequences in Humans and Artificial Intelligence (AI) Hearing Disorders and Deafness | Not yet recruiting | Institut Pasteur | 700 | 2026-09-01 | 2026-07-31 | |
| Investigating the Neural Oscillatory Features for Limited Access to Oral Language in Deaf Children With Early Bilateral Cochlear Implantation Congenital Hearing Loss, Bilateral Cochlear Implants | Not yet recruiting | Institut Pasteur | 150 | 2026-09-01 | 2026-07-31 | |
| Detection of Specific Metabolic Signatures by Nuclear Magnetic Resonance or Metabolomic NMR in Correlation With Markers of Inflammation or Immune Activation and the Risk of Developing Neurocognitive Disorders - Longitudinal Retrospective Study Nested in the ANRS12225 PEDIACAM III Cohort HIV Infection | Not yet recruiting | ANRS, Emerging Infectious Diseases | 128 | 2026-08-01 | 2026-08-18 | |
| Ex Vivo Study of Leukocyte Responses in the Blood of Patients With Leptospirosis and ex Vivo Testing of a New Host-targeted Therapeutic Strategy to Restore Phagocytosis of Leptospira 24 ml blood sample at H0, 16 ml blood sample at H3 - Leptospirosis, Jarisch Herxheimer Reaction | Not yet recruiting | Institut Pasteur | 70 | 2026-07-01 | 2026-05-28 | |
| Safety and Immunogenicity Study of IP-QSV Vaccine in Healthy Adults/Adolescents, Children and Infants 30μg IP-QSV, Placebo, 10μg IP-QSV - Shigella Infection | Phase 1 / Phase 2 | Not yet recruiting | International Vaccine Institute | 370 | 2026-07-01 | 2026-06-24 |
| MAGIA H3S Point of Care Test Performance for HIV, HBV, HCV, and Syphilis Screening in Pregnant Women in DR Congo MAGIA H3S - HIV - Human Immunodeficiency Virus, HBV (Hepatitis B Virus) | Not yet recruiting | Gardiens de Vies | 7500 | 2026-03-01 | 2026-02-05 | |
| Gut Microbiota, Diet-INDuced Obesity and Type 2 Diabetes in New Caledonia - MIND 25 ml blood sample, Urine sample, Stools - Diabetes Mellitus, Type 2, Obesity | Not yet recruiting | Institut Pasteur | 270 | 2026-02-15 | 2026-03-09 | |
| Impact of Sex Hormones on Human Skin Immunity in Health and Hidradenitis Suppurativa (SIAP) Blood sample, skin microbiota and biopsy - Skin Immunity | Not yet recruiting | Institut Pasteur | 240 | 2026-01-01 | 2026-01-09 | |
| A Rhythmic and Auditory Approach for Children With Autism Spectrum Disorders (ASD) EEG recording, Picture recognition test - Autism Spectrum Disorder | Not applicable | Not yet recruiting | Institut Pasteur | 24 | 2026-01-01 | 2025-12-24 |
| Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective Dengue, Chikungunya | Recruiting | Institut Pasteur du Cambodge | 10000 | 2025-12-18 | 2026-01-22 | |
| Cohort Study of Arbovirus and Other Emerging Virus Infections in Fiji: AEVI-Fiji Cohort. Arbovirus Infections, Respiratory Infection Virus | Recruiting | Fiji National University | 910 | 2025-10-23 | 2025-12-01 | |
| Effectiveness of Speech Therapy for Lip-reading in Patients With Hearing Aids: SCED Study Speechreading training - Hearing Loss, Bilateral or Unilateral | Recruiting | Institut Pasteur | 8 | 2025-10-16 | 2026-04-03 | |
| Impact of Breast Milk on the Infectivity and Transmission of Different Viruses "BREASTMILKVIR" Collection breast milk - Breastmilk Collection | Recruiting | Institut Pasteur | 75 | 2025-09-10 | 2025-12-15 |
Showing 20 of 179. Sign in to see all of them.
COVID-19 (16) · HIV Infections (8) · Infections (8) · Sepsis (7) · Severe Acute Respiratory Syndrome (7) · Arbovirus Infections (6) · Dengue (6) · Hepatitis B (6) · Hepatitis C (6) · Influenza, Human (6) · Malaria (6) · Chikungunya Fever (5) · Leptospirosis (5) · Whooping Cough (5) · Zika Virus Infection (5)
Blood Specimen Collection (34) · Surveys and Questionnaires (4) · Defecation (3) · Adjuvants, Pharmaceutic (2) · Aluminum Hydroxide (2) · Data Collection (2) · Saline Solution (2) · Spinal Puncture (2) · 10-valent pneumococcal conjugate vaccine (1) · 13-valent pneumococcal vaccine (1) · 4CMenB vaccine (1) · Albendazole (1) · Anti-Bacterial Agents (1) · Antiparasitic Agents (1) · Artesunate (1)
France (90) · Vietnam (9) · Cameroon (8) · Cambodia (7) · Madagascar (7) · New Caledonia (7) · Belgium (4) · Central African Republic (4) · Côte d’Ivoire (4) · Democratic Republic of the Congo (4) · Egypt (4) · Burkina Faso (3) · China (3) · French Guiana (3) · Guadeloupe (3)
Myrielle Dupont-Rouzeyrol, PhD (4) · Paul Avan, MD (3) · Arnaud Fontanet, MD, PhD (2) · Claude Flamand, PhD (2) · Marc Lecuit (2) · Albert Faye, Pr (1) · Aldiouma Diallo, MD (1)
PMID 35891471, PMID 37871603, PMID 19641202, PMID 20350192, PMID 20658481, PMID 22427678, PMID 22658929, PMID 23945130, PMID 24206649, PMID 24646009, PMID 24690681, PMID 24705410, PMID 25299391, PMID 26351392, PMID 26597653, PMID 27371977, PMID 27591953, PMID 27834029, PMID 28081133, PMID 28139432, PMID 28838639, PMID 29608711, PMID 29796652, PMID 29884695, PMID 30053915, PMID 30514364, PMID 30689757, PMID 30975525, PMID 31051503, PMID 31519223, PMID 31879764, PMID 31955353, PMID 31981287, PMID 31984244, PMID 32034426, PMID 32271796, PMID 32496206, PMID 32638703, PMID 33147165, PMID 33165566, PMID 33186516, PMID 33528568, PMID 33686914, PMID 33709945, PMID 33745731, PMID 33766688, PMID 33876229, PMID 33941622, PMID 34040605, PMID 34171233
2009 (1), 2019 (1)